Introduction {#s1}
============

Breast development is the first step of adolescence in females, and it statistically occurs at 10 yr of age in standard Japanese girls. Girls are defined to be precocious in Japan when breast development occurs at 7.5 yr of age or under ([@r1]). The most common conditions to be diagnosed with precocious breast development are GnRHp-dependent precocious puberty and premature thelarche ([@r2], [@r3]). Early breast development with gonadotropin secretion equal to pubertal levels indicates GnRH-dependent precocious puberty. Premature thelarche is defined as early breast development without other pubertal maturations or an elevation of any sexual hormones. It is useful to distinguish GnRH-dependent precocious puberty from premature thelarche by evaluating the peak LH level and peak LH/FSH ratio by using a GnRH stimulation test ([@r2], [@r3]).

Premature thelarche usually occurs during early childhood before 2 yr of age, and breast development usually improves a few years later ([@r4]). However, it often becomes a problem in causal examinations and treatment to accurately distinguish premature thelarche from precocious puberty. This is especially true if breast development occurs in later childhood such as at 5--7 yr of age.

In this report, GnRH stimulation tests were performed on girls with breast development at 5--7.5 yr of age, and the progression of breast development was discussed by assessing the relationship between prepubertal response and pubertal response to the GnRH stimulation tests.

Participants and Methods {#s2}
========================

Twenty-five girls, who demonstrated breast development from 5 to 7.5 yr of age and, visited Okinawa Prefectural Nanbu Medical Center and Children's Medical Center between 2006 and 2008 were selected for the current study. Of the 25 girls, 4 girls were excluded from the study for the following reasons: two girls were born with birth weights of less than 1,000 g, one girl had a past history of encephalitis, and one girl had no credible information regarding breast development. The remaining 21 girls had no exogenous estrogen intake, and had no intracranial abnormality based on the findings of magnetic resonance imaging (MRI). The clinical characteristics and laboratory data of the 21 girls are summarized in [Table 1](#tbl_001){ref-type="table"}. In the 21 girls with breast development, 11 girls visited within 1 yr after the onset of breast development, while the remaining 10 girls visited more than 1 yr after the onset. Table 1Clinical characteristics of the 21 girls with breast development from 5 to 7.5 yr of ageCases21Chronological age (CA) (yr)7.9 ± 1.0CA at breast development (yr)6.9 ± 0.6Bone age (BA) (yr)9.9 ± 1.4BA/CA ratio1.23 ± 0.10Height (SD)+ 0.74 ± 1.0Obesity (%)+ 14.8 ± 16.7Gestational age (w)38.3 ± 2.5Birth body weight (g)2,764 ± 716Target height (cm)154.9 ± 4.1Mother's menarche (yr)11.6 ± 1.0Data are shown as means ± SD.

The GnRH stimulation test was performed by injecting 3 µg/kg/dose (maximum dose 100 µg) of GnRH into a vein, and the serum levels of LH and FSH at 0, 30, 60, 90 and 120 min after GnRH injection were measured, respectively, by a chemiluminescent immunoassay (CLIA). Pubertal response to the GnRH stimulation test was defined as follows in this study: the peak LH level was 6 mIU/ml or over, and peak LH/FSH ratio is 0.5 or over ([@r5]). The other responses to the GnRH stimulation test were regarded as a prepubertal response. The GnRH stimulation test was started in the daytime, and there were no food restrictions in any of the cases.

Serum IGF-I, estrogen, and DHEA-S levels were measured by an immunoradiometric assay (IRMA), an electrochemiluminescence immunoassay (ECLIA), and a chemiluminescent enzyme immunoassay (CLEIA), respectively.

Bone age was estimated according to the Japanese standard Tanner-Whitehouse 2 (TW2) method through its Radius-Ulna-Short bone (RUS) system ([@r6]). An evaluation of bone age was performed by the author.

A longitudinal analysis was performed in 4 girls who showed a prepubertal response to GnRH at an initial examination. Bone age measurements and a GnRH stimulation test were performed approximately every 6 mo.

All results were expressed as means ± SD. Any correlations between two values were assessed by Pearson's correlation coefficient. Statistical significance was assessed by either the Student's *t-*test or chi-squared analysis. A p value of under 0.05 was considered to be significant.

Results {#s3}
=======

At the initial medical examination, 8 girls showed a prepubertal response to GnRH, while the remaining 13 girls showed a pubertal response to GnRH. Prepubertal responses to GnRH were significantly limited in the cases within 1 yr after the onset of breast development ([Table 2A](#tbl_002){ref-type="table"}). The bone age in the cases with a prepubertal response had accelerated to a level equal to that seen in the cases with a pubertal response, and the advance in bone age was also greater than their chronological age by approximately 20% on average. No significant difference was observed between pubertal response and prepubertal response in regard to any of the clinical characteristics, while IGF-I and estrogen were significantly high in the cases with pubertal response ([Table 2B](#tbl_002){ref-type="table"}). Table 2Comparison between the prepubertal response group and the pubertal response group**A**GnRH stimulation testPrepubertalPubertalp valueCases within 1 yr83\<0.01Cases after 1 yr010Total813**B**GnRH stimulation testPrepubertalPubertalp valueCA at breast development (yr)6.9 ± 0.66.9 ± 0.7NSBA/CA ratio1.19 ± 0.121.25 ± 0.08NSHeight (SD)+ 0.39 ± 1.12+ 0.95 ± 0.90NSObesity (%)+ 9.2 ± 9.7+ 18.3 ± 19.4NSGestational age (w)38.4 ± 2.138.3 ± 2.8NSBirth body weight (g)2,823 ± 7092,726 ± 752NSTarget height (cm)154.0 ± 5.2155.5 ±.4NSMother's menarche (yr)11.6 ± 1.311.5 ± 1.0NSIGF-I (ng/ml)214 ± 64418 ± 148p\<0.01Estrogen (pg/ml)9 ± 422 ± 13p\<0.01DHEA-S (µg/dl)37 ± 3756 ± 25NSData are shown as means ± SD. A: Duration from breast development, B: Clinical characteristics and laboratory data.

In the cross-sectional analysis for the GnRH stimulation test, each peak LH level and peak LH/FSH ratio had a significant correlation with the duration since breast development ([Fig. 1](#fig_001){ref-type="fig"}Fig. 1Correlation of the duration from breast development with the LH peak value (left) or LH/FSH peak ratio (right) in the GnRH stimulation test. The shaded bar indicates the area of the prepubertal response in GnRH stimulation test.); however, no correlations were observed in basal LH level, basal FSH level, or peak FSH level (data not shown).

In the longitudinal analysis of 4 girls with a prepubertal response to the initial GnRH stimulation test, the result for 3 of the 4 girls changed from a prepubertal to a pubertal response at 1 yr or more after the onset of breast development. Case D did not correspond to the definition of a pubertal response to GnRH in this study, but she did show an elevation of both the peak LH level and peak LH/FSH ratio ([Fig. 2](#fig_002){ref-type="fig"}Fig. 2Longitudinal study of the GnRH stimulation test in 4 girls with a prepubertal response at less than 1 yr after breast development. The shaded bar indicates the area of the prepubertal response in GnRH stimulation test.). Height velocity of all 4 of the girls was greater than normal before breast development, and the height velocity did not change either before or after the onset. Similarly, the advance of bone age did not rapidly accelerate after breast development, while the bone age was initially advanced. In both Case A and Case C, early menstruation suddenly occurred at around 9 yr of age ([Fig. 3](#fig_003){ref-type="fig"}Fig. 3Growth curve in 4 girls with a prepubertal response in the GnRH stimulation test at less than 1 yr before the onset of breast development (Cases A to D correspond to A--D in [Fig. 2](#fig_002){ref-type="fig"}). Solid circles, open circles, Xs, and arrows indicate the height, bone age, target height, and growth velocity, respectively.).

Discussion {#s4}
==========

It is important to distinguish premature thelarche from precocious puberty, because precocious puberty needs causal examinations and appropriate treatments. Idiopathic GnRH-dependent precocious puberty, the most common GnRH-dependent precocious puberty, tends to occur frequently in girls ([@r7]). Premature thelarche occurring in later childhood (such as 5--7 yr of age) may be confused with precocious puberty because it sometimes shows an advanced bone age and/or a premature growth spurt ([@r4], [@r8]).

In this study, 8 of 11 cases within 1 yr after the onset of breast development were considered to have premature thelarche, because the LH peak and/or LH/FSH peak ratio demonstrated a prepubertal response to the GnRH stimulation test. In another report that supports our results, 7 of 35 normal females with only breast development of Tanner stage 2 showed a prepubertal response with a peak LH level of under 6.9 IU/l in a GnRH stimulation test ([@r2]). These results mean the possibility of premature thelarche in later childhood is not rare.

Premature thelarche in later childhood may progress to a rapid progressive variant rather than to the slowly progressive variant of precocious puberty. In the longitudinal analysis of this study, the response to the GnRH stimulation test changed from prepubertal to pubertal at the boundary of 1 yr in 3 of 4 cases. This result supports the notion that premature thelarche in later childhood may easily progress to GnRH-dependent precocious puberty. In further observation of the 4 cases, 2 of the 4 cases showed early menstruation. It was previously reported that premature thelarche would rarely progress to GnRH dependent precocious puberty ([@r9]), but in other reports, it was reported that premature thelarche might sometimes accelerate the timing of puberty ([@r10]) and that premature thelarche in later childhood also has a high risk of precocious puberty ([@r8]). It must be always considered whether premature thelarche in later childhood changes to GnRH dependent precocious puberty.

The mechanism of premature thelarche in later childhood is unknown, but some reports have mentioned that exogenous estrogen ([@r11]), some foods ([@r12]) or drugs ([@r13]) might be related. Actually, several reports have implied that environmental pollutants appear to have induced local epidemics of the onset of premature thelarche in later childhood and precocious puberty ([@r14],[@r15],[@r16]). Recently, an activating mutation in G protein-coupled receptor (GPR) 54 was found to lead to the onset of central precocious puberty, while the initial GnRH stimulation test showed only a borderline-pubertal response like premature thelarche in later childhood ([@r17]).

According to statistics obtained from the Ministry of Health, Labour, and Welfare in Japan, the prevalence of precocious puberty in Okinawa is 4.5 times more than the Japanese standard in girls, whereas no such difference is observed in boys ([Table 3](#tbl_003){ref-type="table"}). It is uncertain in Okinawa whether the high prevalence of precocious puberty is a consequence of local epidemics of premature thelarche in later childhood. Although further studies need to elucidate why the prevalence of precocious puberty is high in girls in Okinawa, premature thelarche in later childhood might be specific to Okinawa. Table 3 Number of patients with precocious puberty, according to the statistics of the Ministry of Health, Labour, and Welfare in Japan in 2004*(modified)*BoysGirlsNumberPrevalence\*NumberPrevalence\*Okinawa52.99655.5Japan1912.01,17812.3\*Prevalence among 100,000 people under 20 yr of age.

In conclusion, for an adequate evaluation of breast development in later childhood, careful observations for 1 yr or more are recommended, even if all clinical characteristics and data are compatible with premature thelarche at first, because the response to the GnRH stimulation test can change from prepubertal to pubertal up to about 1 yr after breast development.
